Answer:
=> 1366.120 g/mL.
Explanation:
To determine the formula to use in solving such a problem, you have to consider what you have been given.
We have;
mass (m) = 25 Kg
Volume (v) = 18.3 mL.
From our question, we are to determine the density (rho) of the rock.
The formula:
First let's convert 25 Kg to g;
1 Kg = 1000 g
25 Kg = ?
= 25000 g
Substitute the values into the formula:
= 1366.120 g/mL.
Therefore, the density (rho) of the rock is 1366.120 g/mL.
Answer:
6.88 mg
Explanation:
Step 1: Calculate the mass of ³²P in 175 mg of Na₃³²PO₄
The mass ratio of Na₃³²PO₄ to ³²P is 148.91:31.97.
175 mg g Na₃³²PO₄ × 31.97 g ³²P/148.91 g Na₃³²PO₄ = 37.6 mg ³²P
Step 2: Calculate the rate constant for the decay of ³²P
The half-life (t1/2) is 14.3 days. We can calculate k using the following expression.
k = ln2/ t1/2 = ln2 / 14.3 d = 0.0485 d⁻¹
Step 3: Calculate the amount of P, given the initial amount (P₀) is 37.6 mg and the time elapsed (t) is 35.0 days
For first-order kinetics, we will use the following expression.
ln P = ln P₀ - k × t
ln P = ln 37.6 mg - 0.0485 d⁻¹ × 35.0 d
P = 6.88 mg
Answer:
A.The Atlantic Ocean has more mid-ocean ridges than the Pacific Ocean so that keeps it growing larger.
Explanation:
Atlantic ocean is getting bigger because of the presence of spreading centers (divergent plate boundary). ... Pacific Ocean is getting smaller because the pacific plate is subducting along the subduction zones. Subduction zones are areas where old, dense plate subducts beneath a less dense plate.
Answer: the top one is 5.3 s and the bottom one is tenths of seconds
Explanation:
Cyclic nucleotides cAMP and cGMP are part of almost all major cellular signaling pathways. Phosphodiesterases (PDEs) are enzymes that regulate the intracellular levels of cAMP and cGMP. Protein kinase A or cAMP-dependent protein kinase mediates most cAMP effects in the cell. Over the last 25 years, various components of this group of molecules have been involved in human diseases, both genetic and acquired. Lately, the PDEs attract more attention. The pharmacological exploitation of the PDE’s ability to regulate cGMP and cAMP, and through them, a variety of signaling pathways, has led to a number of new drugs for diverse applications from the treatment of erectile dysfunction to heart failure, asthma, and chronic obstructive pulmonary disease. We present the abstracts (available online) and selected articles from the proceedings of a meeting that took place at the National Institutes of Health (NIH), Bethesda, MD, June 8–10, 2011.
